Filing Flows › Stemtech (STEK) › Q1 2025
Stemtech (STEK) Q1 2025 earnings results (first quarter 2025)
10-Q filed Jul 17, 2025
Stemtech (STEK) reported revenue of $868K for the first quarter 2025 (Q1 2025), -37% from a year earlier and -34% from the quarter before. Operating margin was -138.8%, net loss $1.5M (168.0% of revenue).
Stemtech, Q1 2025: revenue $868K (-37% year over year), operating margin -138.8%, net loss $1.5M, operating cash flow −$711K. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $868K | -34% | -37% |
| Operating profit | −$1.2M | -3733% | — |
| Net earnings | −$1.5M | — | — |
| Operating cash flow | −$711K | — | — |
What changed
Revenue was $868K in Q1 2025, down 37% year over year and down 34% from the previous quarter.
Gross margin was 83.0%, up 8.0 points from a year earlier. Operating costs exceeded revenue by $1.2M, an operating margin of -138.8%. Operating expenses fell 6% while revenue fell 37%. The quarter ended with a net loss of $1.5M, wider than the previous quarter's $397K loss. Minority interests bore $3K of it: to shareholders the quarter was a loss of $1.5M.
Operating cash flow was −$711K. Non-cash charges added back $42K of depreciation and amortization and $108K of share-based compensation. Working capital and other items added $598K.
Questions
What was Stemtech's revenue in the first quarter 2025?
Stemtech (STEK) reported revenue of $868K for the first quarter 2025 (Q1 2025), -37% from a year earlier and -34% from the quarter before.
Was Stemtech profitable in the first quarter 2025?
Operating loss was $1.2M (-138.8% of revenue) and net loss $1.5M.
Source: Stemtech 10-Q on SEC EDGAR.